Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments
Frédéric Clarembeau, Georgia Bale, Nicolas Lanthier
Clinical Science (2020) Vol. 134, Iss. 16, pp. 2117-2135
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Cirrhosis-associated immune dysfunction
Agustı́n Albillos, Rosa Martín‐Mateos, Van der Merwe, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 2, pp. 112-134
Open Access | Times Cited: 249
The crucial role and mechanism of insulin resistance in metabolic disease
Xuefei Zhao, Xuedong An, Cunqing Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 211
Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement
Jiacheng Liu, Jinqiang Ma, Chongtu Yang, et al.
Radiology (2022) Vol. 303, Iss. 3, pp. 711-719
Closed Access | Times Cited: 69
Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
Silvia Espina, Diego Casas Deza, Vanesa Bernal Monterde, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3487-3487
Open Access | Times Cited: 22
Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ?
Quentin Binet, Audrey Loumaye, Vanessa Preumont, et al.
Acta Gastro Enterologica Belgica (2022) Vol. 85, Iss. 2, pp. 346-357
Open Access | Times Cited: 26
Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?
Nicolas Lanthier, Nathalie M. Delzenne
Cells (2022) Vol. 11, Iss. 17, pp. 2718-2718
Open Access | Times Cited: 20
Liver damage and immune responses
Carl-Philipp Hackstein
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 01, pp. 56-64
Closed Access
Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis
Ninghui Zhao, Jinjia Bai, Xinmiao Li, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Unraveling the Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions
Rashid Mir, Mohammed Jeelani, Muffarah Hamid Alharthi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2770-2770
Open Access
The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis
Huanli Jiao, Han Wang, Jia Li, et al.
Seminars in Liver Disease (2025)
Closed Access
Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress
Lele Cheng, Tao Chen, Manyun Guo, et al.
Clinical Science (2021) Vol. 135, Iss. 14, pp. 1689-1706
Open Access | Times Cited: 26
Malnutrition is highly prevalent in hospitalized cirrhotic patients and associates with a poor outcome
C. Dumont, Fabien Wuestenberghs, Nicolas Lanthier, et al.
Acta Gastro Enterologica Belgica (2022) Vol. 85, Iss. 2, pp. 311-319
Open Access | Times Cited: 17
Improving the prognosis before and after liver transplantation: Is muscle a game changer?
Alexis Goffaux, Alicia Delorme, Géraldine Dahlqvist, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 40, pp. 5807-5817
Open Access | Times Cited: 17
Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target?
Guillaume Hénin, Nicolas Lanthier, Géraldine Dahlqvist
Acta Gastro Enterologica Belgica (2022) Vol. 85, Iss. 4, pp. 611-624
Open Access | Times Cited: 17
Liver Fetuin-A at Initiation of Insulin Resistance
Nicolas Lanthier, Valérie Lebrun, Olivier Molendi‐Coste, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1023-1023
Open Access | Times Cited: 13
Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction‐associated steatotic liver disease?
Guillaume Hénin, Audrey Loumaye, Louise Deldicque, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1781-1796
Open Access | Times Cited: 2
Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiota
Siyuan Sun, Guangheng Zhang, Shimeng Lv, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents
Coralie Hamoir, Yves Horsmans, Peter Stärkel, et al.
Acta Gastro Enterologica Belgica (2021) Vol. 84, Iss. 1, pp. 25-32
Open Access | Times Cited: 15
Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B—A Retrospective Cohort Study
Qingxia Wang, Jiao Xue, Meijie Shi, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 2311-2322
Open Access | Times Cited: 10
Severe insulin resistance in a patient with diabetes after treatment with brentuximab vedotin
G. Peeters, Ann Verhaegen
BMJ Case Reports (2024) Vol. 17, Iss. 4, pp. e251867-e251867
Closed Access | Times Cited: 1
The Intestinal Microbiome and the Metabolic Syndrome—How Its Manipulation May Affect Metabolic-Associated Fatty Liver Disease (MAFLD)
Stephen Malnick, Sheral Ohayon Michael
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 9, pp. 7197-7211
Open Access | Times Cited: 3
Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity?
Nicolas Lanthier, Peter Stärkel, Géraldine Dahlqvist
Clinics and Research in Hepatology and Gastroenterology (2021) Vol. 45, Iss. 4, pp. 101721-101721
Closed Access | Times Cited: 5
Quelle alimentation proposer aux patients présentant une stéatohépatite non-alcoolique ?
Stéphanie André-Dumont, Nicolas Lanthier
Nutrition Clinique et Métabolisme (2022) Vol. 36, Iss. 1, pp. 12-20
Closed Access | Times Cited: 3
Glucose turnover at whole-body and skeletal muscle level in response to parenteral nutrition in male patients with alcoholic liver cirrhosis
Beckey Trinh, Anders R. Nielsen, Ulrik Winning Iepsen, et al.
Clinical Nutrition ESPEN (2024) Vol. 60, pp. 240-246
Open Access
Patients with chronic liver diseases are at risk for diabetes even before development of cirrhosis
Georgia Bale, Frédéric Clarembeau, Peter Stärkel, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 8, pp. 102428-102428
Closed Access
Page 1 - Next Page

Scroll to top